查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590761

製劑開發外包市場：按服務、劑型和應用分類 - 2025-2030 年全球預測

Formulation Development Outsourcing Market by Service (Formulation Optimization, Pre-formulation Services), Dosage Form (Injectable, Oral, Topical), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥品開發外包市場規模為400.1億美元，預計2024年將達437.6億美元，複合年成長率為9.85%，預計到2030年將達到772.6億美元。

製劑開發外包涉及與專業製藥公司簽訂契約，以創新和最佳化對藥物開發過程至關重要的製劑。這種需求源自於對專業知識的需求，以克服複雜的配方挑戰、最佳化生物有效性、確保穩定性並滿足監管要求，同時縮短上市時間。應用涵蓋癌症、神經病學和感染疾病等多個治療領域，最終用途主要在製藥和生物技術行業。市場開拓受到對具有成本效益的藥物開發的需求不斷成長、複雜的生物藥物分子的增加以及缺乏內部資源的中小型生物技術公司的激增的影響。擴大服務範圍存在商機，包括先進的藥物輸送系統、個人化醫療接觸點以及使用數位技術增強的配方流程。對公司的建議包括投資人工智慧和機器學習等技術平台，以提高預測制定和流程效率，並建立策略夥伴關係以加強服務組合。

主要市場統計
基準年[2023] 400.1億美元
預測年份 [2024] 437.6億美元
預測年份 [2030] 772.6億美元
複合年成長率（%） 9.85%

然而，這個市場面臨挑戰，包括嚴格的監管環境、智慧財產權問題和高昂的技術實施成本。此外，還存在來自大公司內部開發能力的競爭壓力以及外包模式固有的品管問題的風險。推動成長的創新領域包括用於永續配方的生物分解性聚合物、用於靶向藥物傳輸的奈米配方以及採用連續製造程序。對市場情勢的了解表明，由於快速的技術進步和聯合研究，市場是動態的且高度發展的。隨著公司尋求差異化，專注於創建滿足各種治療方法和客戶需求的全面且靈活的服務解決方案非常重要。與學術研究機構的合作是獲取新調查方法和保持領先新趨勢的強大優勢。

市場動態：揭示快速發展的製劑開發外包市場的關鍵市場洞察

供需的動態交互作用正在改變藥物開發外包市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 由於慢性病和感染疾病的沉重負擔，對新藥的需求不斷增加
    • 許多注意力集中在開發難溶性化合物以提高生物有效性度。
    • 全球臨床試驗快速增加
  • 市場限制因素
    • 藥物研發外包高成本
  • 市場機會
    • 增加研發費用改善藥品開發外包服務
    • 製劑開發新技術的開發
  • 市場挑戰
    • 與製劑開發外包相關的品管複雜性

波特五力：駕馭製劑開發外包市場的策略工具

波特的五力架構是了解藥物開發外包市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥物開發外包市場的外部影響

外部宏觀環境因素在塑造藥物開發外包市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解製劑開發外包市場的競爭狀況

藥品開發外包市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣製劑開發外包市場供應商績效評估

FPNV定位矩陣是評估製劑開發外包市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製製劑開發外包市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對藥物開發外包市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於慢性病和感染疾病的沉重負擔，對新藥的需求不斷增加。
      • 專注於開發難溶性化合物以提高生物有效性
      • 全球臨床研究數量迅速增加
    • 抑制因素
      • 外包藥物研發的成本很高。
    • 機會
      • 增加研發費用改善藥品開發外包服務
      • 製劑開發新技術的開發
    • 任務
      • 與製劑開發外包相關的品管複雜性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥品開發外包市場：依服務分類

  • 處方最佳化
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段
  • 預先處方服務
    • 分析服務
    • 探索性和臨床前服務

第7章以劑型分類的製劑開發外包市場

  • 可注射的
  • 口服
  • 話題

第8章 藥品開發外包市場：依應用分類

  • 心血管
  • 遺傳疾病
  • 感染疾病
  • 神經病學
  • 腫瘤學
  • 呼吸系統

第9章 北美和南美製劑開發外包市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太製劑開發外包市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲製劑開發外包市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Aizant Drug Research Solutions Private Limited
  • Cambrex Corporation
  • Catalent Inc.
  • Emergent Biosolutions Inc.
  • Eurofins Scientific SE
  • Intertek Group PLC
  • Jubilant Pharmova Limited
  • Lonza Group AG
  • Piramal Group
  • Quotient Sciences Limited
  • Recipharm AB
  • Samsung Biologics Co., Ltd.
  • SGS SA
  • Siegfried AG
  • Syngene International Limited
Product Code: MRR-0D217D5AE50B

The Formulation Development Outsourcing Market was valued at USD 40.01 billion in 2023, expected to reach USD 43.76 billion in 2024, and is projected to grow at a CAGR of 9.85%, to USD 77.26 billion by 2030.

Formulation Development Outsourcing involves contracting specialized pharmaceutical companies to innovate and optimize formulations for drug products, which is integral to the drug development process. The necessity arises from the need for expertise in navigating complex formulation challenges, optimizing bioavailability, ensuring stability, and meeting regulatory requirements, all while accelerating time to market. Application spans across multiple therapeutic areas, including oncology, neurology, and infectious diseases, with end-use primarily in pharmaceutical and biotechnology industries. Market growth is influenced by the rising demand for cost-effective drug development, the increase in complex and biological drug molecules, and the surge of small to medium-sized biotech firms lacking internal resources. Opportunities lie in expanding service offerings to include advanced drug delivery systems, personalized medicine touchpoints, and leveraging digital technologies for enhanced formulation processes. Recommendations for businesses include investing in technology platforms like AI and machine learning for predictive formulation and enhanced process efficiencies, and forming strategic partnerships to enhance service portfolios.

KEY MARKET STATISTICS
Base Year [2023] USD 40.01 billion
Estimated Year [2024] USD 43.76 billion
Forecast Year [2030] USD 77.26 billion
CAGR (%) 9.85%

However, this market faces challenges such as stringent regulatory landscapes, IP concerns, and the high cost of technology adoption. Additionally, there is a competitive pressure from in-house development capabilities of larger firms and the risk of quality control issues inherent to outsourcing models. To foster growth, areas of innovation include biodegradable polymers for sustainable formulations, nanoformulation for targeted drug delivery, and adoption of continuous manufacturing processes. Insight into the market's nature reveals a dynamic and highly evolving landscape driven by rapid technological advancements and collaborations. As companies strive for differentiation, an emphasis on building comprehensive and flexible service solutions that meet diverse therapeutic and client needs will be critical. Engaging in collaboration with academic research institutions can provide a significant edge in accessing novel formulation methodologies and staying ahead of emerging trends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Formulation Development Outsourcing Market

The Formulation Development Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for new drugs owing to the high burden of chronic and infectious diseases
    • Huge focus on developing poorly water-soluble compounds to improve bioavailability
    • Rapidly growing number of clinical studies globally
  • Market Restraints
    • High cost of formulation development outsourcing
  • Market Opportunities
    • Increasing R&D spending to improve the formulation development outsourcing services
    • Development of new technologies for formulation development
  • Market Challenges
    • Quality control complexities associated with formulation development outsourcing

Porter's Five Forces: A Strategic Tool for Navigating the Formulation Development Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Formulation Development Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Formulation Development Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Formulation Development Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Formulation Development Outsourcing Market

A detailed market share analysis in the Formulation Development Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Formulation Development Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Formulation Development Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Formulation Development Outsourcing Market

A strategic analysis of the Formulation Development Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Formulation Development Outsourcing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aizant Drug Research Solutions Private Limited, Cambrex Corporation, Catalent Inc., Emergent Biosolutions Inc., Eurofins Scientific SE, Intertek Group PLC, Jubilant Pharmova Limited, Lonza Group AG, Piramal Group, Quotient Sciences Limited, Recipharm AB, Samsung Biologics Co., Ltd., SGS S.A., Siegfried AG, and Syngene International Limited.

Market Segmentation & Coverage

This research report categorizes the Formulation Development Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Formulation Optimization and Pre-formulation Services. The Formulation Optimization is further studied across Phase I, Phase II, Phase III, and Phase IV. The Pre-formulation Services is further studied across Analytical Services and Discovery & Preclinical Services.
  • Based on Dosage Form, market is studied across Injectable, Oral, and Topical.
  • Based on Application, market is studied across Cardiovascular, Genetic Disorders, Infectious Diseases, Neurology, Oncology, and Respiratory.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for new drugs owing to the high burden of chronic and infectious diseases
      • 5.1.1.2. Huge focus on developing poorly water-soluble compounds to improve bioavailability
      • 5.1.1.3. Rapidly growing number of clinical studies globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of formulation development outsourcing
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing R&D spending to improve the formulation development outsourcing services
      • 5.1.3.2. Development of new technologies for formulation development
    • 5.1.4. Challenges
      • 5.1.4.1. Quality control complexities associated with formulation development outsourcing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Formulation Development Outsourcing Market, by Service

  • 6.1. Introduction
  • 6.2. Formulation Optimization
    • 6.2.1. Phase I
    • 6.2.2. Phase II
    • 6.2.3. Phase III
    • 6.2.4. Phase IV
  • 6.3. Pre-formulation Services
    • 6.3.1. Analytical Services
    • 6.3.2. Discovery & Preclinical Services

7. Formulation Development Outsourcing Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Formulation Development Outsourcing Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Genetic Disorders
  • 8.4. Infectious Diseases
  • 8.5. Neurology
  • 8.6. Oncology
  • 8.7. Respiratory

9. Americas Formulation Development Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Formulation Development Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Formulation Development Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aizant Drug Research Solutions Private Limited
  • 3. Cambrex Corporation
  • 4. Catalent Inc.
  • 5. Emergent Biosolutions Inc.
  • 6. Eurofins Scientific SE
  • 7. Intertek Group PLC
  • 8. Jubilant Pharmova Limited
  • 9. Lonza Group AG
  • 10. Piramal Group
  • 11. Quotient Sciences Limited
  • 12. Recipharm AB
  • 13. Samsung Biologics Co., Ltd.
  • 14. SGS S.A.
  • 15. Siegfried AG
  • 16. Syngene International Limited

LIST OF FIGURES

  • FIGURE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FORMULATION DEVELOPMENT OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DISCOVERY & PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023